PRELUDE CAPITAL MANAGEMENT, LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 246 filers reported holding HAEMONETICS CORP in Q3 2021. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$415,830
-25.7%
4,642
-47.6%
0.03%
+68.8%
Q1 2022$560,000
-40.6%
8,857
-33.7%
0.02%
-33.3%
Q3 2021$943,000
-9.8%
13,352
-14.9%
0.02%
-22.6%
Q2 2021$1,046,000
-58.9%
15,693
-31.5%
0.03%
-52.3%
Q1 2021$2,542,000
+23.5%
22,897
+32.1%
0.06%
+25.0%
Q4 2020$2,058,000
+350.3%
17,328
+230.9%
0.05%
+136.4%
Q3 2020$457,000
+7.8%
5,237
+10.7%
0.02%
-4.3%
Q2 2020$424,000
+3161.5%
4,731
+4162.2%
0.02%
Q4 2019$13,000
-89.7%
111
-97.5%
0.00%
-100.0%
Q2 2016$126,000
+75.0%
4,362
+171.8%
0.02%
+80.0%
Q1 2015$72,0001,6050.01%
Other shareholders
HAEMONETICS CORP shareholders Q3 2021
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders